Skip to main content
SpringerLink
Log in

Soft Tissue Augmentation

  • Chapter
Evaluation and Treatment of the Aging Face

Abstract

Soft tissue augmentation—the ability to soften and build up the tissue of the face by means other than surgical—has actually been attempted for centuries. Substances used in the past such as beeswax and paraffin were not only not particularly effective but often caused devastating complications, even death.1 In the modern era, various substances have been used to augment and soften the features of the face, but no perfect material yet exists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barton JL, Cunliff WJ. The subcutaneous fat: oil granuloma. In: Textbook of Dermatology, AS Rook, DS Wilkinson, FJ Eberling, RH Champion, JL Burton, eds. Blackwell Press, Oxford, 1986, p. 1870.

    Google Scholar 

  2. Elson ML. Clinical assessment of Zyplast implant: a year of experience for soft tissue contour correction. J Am Acad Dermatol. 1988;18:707.

    Article  CAS  PubMed  Google Scholar 

  3. FDA approval letter to Collagen Corporation, July 22, 1981.

    Google Scholar 

  4. FDA approval letter to Collagen Corporation, June 24, 1985.

    Google Scholar 

  5. Zyderm skin test package insert. Collagen Corporation, Palo Alto, California, 1991.

    Google Scholar 

  6. Elson ML. Soft tissue augmentation: a review of available materials. Cosmet Dermatol. 1991;4[1]:10.

    Google Scholar 

  7. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol. 1989;15:301.

    CAS  PubMed  Google Scholar 

  8. Klein AW. In favor of double testing. J Dermatol Surg Oncol. 1989;15:263.

    CAS  PubMed  Google Scholar 

  9. Elson ML. Soft tissue augmentation of periorbital fine lines and the orbital groove with Zyderm I and fine-gauge needles. J Dermatol Surg Oncol. 1992; 18:779.

    CAS  PubMed  Google Scholar 

  10. Elson ML. Communication is imperative regarding side effects of soft tissue augmentation. Cosmet Dermatol. 1991;4[3]:8.

    Google Scholar 

  11. Elson ML. Techniques for lip augmentation discussed. Cosmet Dermatol. 1990;3[11]:16.

    Google Scholar 

  12. Elson ML. Collagen Implantation. In: Complications of Dermatologic Surgery, H Harahap, ed. Springer-Verlag, Heidelberg, 1993, pp. 91–100.

    Google Scholar 

  13. Cucin RL, Barek D. Complications of injectable collagen implants. Plast Reconstr Surg. 1983; 71:731.

    CAS  PubMed  Google Scholar 

  14. Zyderm/Zyplast physician package insert. Collagen Corporation, Palo Alto, California, 1991.

    Google Scholar 

  15. Hanke DW, Stegman SJ, et al. Abscess formation and local necrosis following treatment with Zyderm and Zyplast collagen implant. J Am Acad Dermatol. 1991;25:319.

    Article  CAS  PubMed  Google Scholar 

  16. Letter from Collagen Corporation to Physicians, April 16, 1990.

    Google Scholar 

  17. Elson ML. Dermal filler materials. Dermatologic Clin. 1993;11:361–367.

    CAS  Google Scholar 

  18. Elson ML. Injectable collagen and autoimmune disease [editorial]. J Dermatol Surg Oncol. 1993;19:165–168.

    CAS  PubMed  Google Scholar 

  19. Ishikawa T, Ogura T, et al. Clinical study of injectable atelocollagen from bovine calk skin. Nishinihon Hifuka. 1985; 47(7).

    Google Scholar 

  20. Lyon MC, Block DA, et al. Predisposing factors in polymyositis/dermatomyositis: results of a nationwide survey. J Rheumatol. 1989;16:1218.

    CAS  PubMed  Google Scholar 

  21. Personal communication. Dr. Dan Jolivette, Collagen Corporation, Palo Alto, California, May 1992.

    Google Scholar 

  22. News release from American College of Rheumatology, 1991.

    Google Scholar 

  23. 1989 Advisory Panel to the FDA

    Google Scholar 

  24. 1991 Advisory Panel to the FDA

    Google Scholar 

  25. Ramey vs. Collagen Corporation, case number 85–57338, District Court of Harris County, Texas, 270 Judicial District.

    Google Scholar 

  26. Ruling by Texas Appellant Court August 28, 1991

    Google Scholar 

  27. Millikan L, Rosen T, et al. Treatment of depressed cutaneous scars with gelatin matrix implant: a multicenter study. J Am Acad Dermatol. 1987;16:1155.

    Article  Google Scholar 

  28. Millikan L, Banks K, et al. A 5-year safety and efficacy evaluation with Fibrel in the correction of cutaneous scars following one or two treatments. J Dermatol Surg Oncol. 1991;17:223.

    CAS  PubMed  Google Scholar 

  29. Mohheit GD. Fibrel injection techniques in cutaneous scars for soft-tissue augmentation and wrinkles. Cosmet Dermatol. 1991;5[4]:10.

    Google Scholar 

  30. Fibrel package insert. Mentor, Goleta, California.

    Google Scholar 

  31. June 11, 1991, testimony of FDA commissioner Dr. David Kessler before the House of Representatives Human Resources and Intergovernmental Relations Subcommittee re: promoting drugs for unapproved uses.

    Google Scholar 

  32. Selmanowitz VJ, Orentreich N. Medical-grade fluid silicone: a monographic review. J Dermatol Surg Oncol. 1977;3:597.

    CAS  PubMed  Google Scholar 

  33. Kessler before Congress re: breast implants, February 1992.

    Google Scholar 

  34. Ishikawa T, Ogura T, et al. Clinical study of injectable Atelocollagen from bovine calf skin. Nishinihon Hifuka. 1985;47(7).

    Google Scholar 

  35. Koken Atelocollagen Implant package insert, Koken Bioscience Institute, Tokyo, Japan.

    Google Scholar 

  36. Dierickx P, Dermueaux L. Comparative study of the clinical efficiency of a 2% collagen solution and a 3.5% collagen dispersion on 60 patients. Presented at the 5th International Society for Dermatologic Surgery, Jerusalem, Israel, October 28–31, 1984.

    Google Scholar 

  37. Personal communication. Dr. A Julius Newmann, Philadelphia, Pennsylvania, May 1992.

    Google Scholar 

  38. Ersek RA, Geisang AA III. Bioplastique soft tissue augmentation. Plast Reconstr Surg. 1990; 693. Vol. 85. # 6

    Google Scholar 

  39. Walter CC. The use of Gore-Tex for facial augmentation. Presented at the 12th International Society for Dermatologic Surgery, Munich, Germany, October 4–7, 1991.

    Google Scholar 

  40. Piacquadio, D. Hyalin gel: a new substance for soft tissue augmentation. Am Acad Dermat 51st Annual meeting, San Francisco, California, Dec 5–10, 1992.

    Google Scholar 

  41. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with Botulinum A exotoxin. J Dermatol Surg Oncol. 1992; 18:17.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Melvin L. Elson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Dermatology Center, Inc., 4535 Harding Road, 37205-2120, Nashville, TN, USA

    Melvin L. Elson M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Elson, M.L. (1995). Soft Tissue Augmentation. In: Elson, M.L. (eds) Evaluation and Treatment of the Aging Face. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8401-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-8401-4_7

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-8403-8

  • Online ISBN: 978-1-4613-8401-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation